FundedIQ
Biotechnology

Zosano Pharma: Funding, Investors & Team (Oct 2026)

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.

zosanopharma.com LinkedIn Fremont, United States 51-100 employees
Biopharma Biotechnology Medical
Total raised
$15.4M
Rounds
1
Latest
Post-IPO Debt
Feb 2022

Zosano Pharma has raised $15.4M across 1 funding round on record, the most recent a Post-IPO Debt of $15.4M announced in Feb 2022.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Zosano Pharma Company Profile and Key Stats

Total funding raised
$15.4M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Debt
$15.4M in Feb 2022
Employees
51-100
reported band
Headquarters
Fremont, United States

Latest funding round on record: Feb 2022.

Zosano Pharma Funding Rounds

Date
Round
Amount
Post-IPO Debt
$15.4M

Zosano Pharma Founders and Leadership Team

Name
Role
Contact
Steve Lo
CEO
Locked

Contact details for the Zosano Pharma team: 1 of 1 has an email address on file.

Start 14-day free trial →

Zosano Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Zosano Pharma's latest round of $15.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Zosano Pharma in Biotechnology and Fremont

Companies Similar to Zosano Pharma

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Zosano Pharma Funding FAQs

What does Zosano Pharma do?

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.

How much funding has Zosano Pharma raised?

Zosano Pharma has raised $15.4M across 1 round on record. The most recent is a Post-IPO Debt of $15.4M announced in Feb 2022.

When did Zosano Pharma last raise funding?

Zosano Pharma's most recent funding round on record is a Post-IPO Debt of $15.4M, announced in Feb 2022.

Who is the CEO of Zosano Pharma?

Steve Lo is listed as CEO at Zosano Pharma.

Where is Zosano Pharma headquartered?

Zosano Pharma is based in Fremont, California, United States.

How many employees does Zosano Pharma have?

Zosano Pharma is in the 51-100 employee band.

How does Zosano Pharma's funding compare to other Biotechnology startups?

Zosano Pharma's latest round of $15.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Zosano Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zosano Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.